IL17A and colitis: Unfortunately, this colonic immunomodulatory effect of SmSWP could not be confirmed at the protein level by ELISA analysis: no direct statistical significant differences were found between SmSWP-treated and PBS-treated colitis mice but curative administration of SmSWP did lower the concentrations of IFN-γ and IL-17A in the colon supernatants, resulting in a loss of significance between these SmSWP-treated colitis and control mice.